Institutional investors hold a majority ownership of ACOR through the 98.34% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2013, these large investors purchased a net $786.4 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRANKLIN ADVISERS, INC. Bought 676.1 Thousand shares of Acorda Therapeutics Inc
BLACKROCK FUND ADVISORS Bought 460.8 Thousand shares of Acorda Therapeutics Inc